近25 年来，骨髓瘤（MM）的治疗得到了长足进步，表现在治疗上新的治疗手段的增加，如硼替佐米、来那度胺等，以及相应的分子生物学发展，但高危 MM 患者却不能从新的治疗手段中获益。 高危MM 患者大...
nearly 25 years, the treatment of multiple myeloma (mm) of obtained the considerable progress, the new treatment means that the increase in the treatment, such as boron for bortezomib, lenalidomide, etc., and the corresponding molecular biology development, but high-risk MM patients, but not from the treatment benefit. High risk MM patients...
